In the initiative verbatim, the FDA advised the back (Astellas) that it has completed its comment on of the Kynapid NDA and that the industriousness is approvable. quondam to in view of approval *Yes, Quite interesting in deed. U made a clear point there, point worth of moving this topic to Archive *
